Physician profile

Daryl Keith Houston

Pulmonary Disease · Culver City, CA

NPI 1295861433

$6,516.16

in general payments reported to CMS, 2019-2025

37 companies · $630 in 2025

The $630 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,530.77

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,529.54 2019-2025 Trelegy Ellipta, Arexvy, Nucala
Astrazeneca Pharmaceuticals LP $867.97 2019-2025 Breztri, Tezspire
Boehringer Ingelheim Pharmaceuticals, INC. $804.18 2019-2025 Ofev, Jardiance, Jascayd
Mylan Specialty L.P. $313.83 2019-2024 Yupelri
Genzyme Corporation $268.53 2022-2023
Mallinckrodt Hospital Products INC. $260.70 2020-2023 Acthar
Insmed, INC. $227.03 2023-2025 Arikayce, Brinsupri
Abbvie INC. $204.08 2021-2024
Advanced Respiratory, INC $197.53 2019-2021
Baxter Healthcare $180.91 2022-2024 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Sunovion Pharmaceuticals INC. $164.12 2019
Bayer Healthcare Pharmaceuticals INC. $149.44 2019
Lilly USA, LLC $140.30 2022-2025 Mounjaro, Zepbound
Gilead Sciences, INC. $133.67 2019-2021
Sanofi-Aventis U.S. LLC $96.50 2022
Show all 37 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $95.37 2019-2022
Janssen Pharmaceuticals, INC $85.66 2021-2024 Xarelto
Philips North America LLC $82.43 2024-2025 (Ak6) Vest Therapy, Vest Therapy Und
Viatris Specialty LLC $76.18 2025 Yupelri
Mallinckrodt Enterprises LLC $65.68 2019
Paratek Pharmaceuticals, INC. $61.14 2023 Nuzyra
Pfizer INC. $58.16 2020-2024
Allergan, INC. $55.41 2019-2020
Tactile Systems Technology INC $46.02 2021
Biosense Webster, INC. $43.83 2021
Intuitive Surgical, INC. $43.53 2019
Electromed, INC. $37.10 2024 Smartvest
Pulmonx Corporation $31.23 2022-2023 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter
Actelion Pharmaceuticals US, INC. $31.18 2020
La Jolla Pharmaceutical Company $26.18 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $22.38 2024 Xifaxan
Medtronic, INC. $21.98 2022
Horizon Therapeutics Plc $21.61 2023 Tepezza
Tetraphase Pharmaceuticals, INC. $20.78 2019
Novartis Pharmaceuticals Corporation $18.42 2022
Exact Sciences Corporation $16.91 2025 The Cologuard Plus Collection Kit
Nestle Healthcare Nutrition INC. $16.65 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daryl Keith Houston

$6,516.16

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $630 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/13786/daryl-keith-houston

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.